| Title: |
Anti-Lipase Potential of the Organic and Aqueous Extracts of Ten Traditional Edible and Medicinal Plants in Palestine; a Comparison Study with Orlistat |
| Authors: |
Nidal Jaradat; Abdel Naser Zaid; Fatima Hussein; Maram Zaqzouq; Hadeel Aljammal; Ola Ayesh |
| Source: |
Medicines, Vol 4, Iss 4, p 89 (2017) |
| Publisher Information: |
MDPI AG |
| Publication Year: |
2017 |
| Collection: |
Directory of Open Access Journals: DOAJ Articles |
| Subject Terms: |
anti-obesity; anti-lipase; traditional medicine; folkloric food; Medicine |
| Description: |
Background: Herbs have played a fundamental and essential role in the humans life since ancient times, especially those which are used as food and/or folk medicinedue to both their nutritive and curative properties.This study aimed to investigate new antilipase agents from tentraditional Palestinian edible and medicinal plants through inhibition of the absorption of dietary lipids. Methods: The anti-lipase activity for ten plants was evaluated and compared with the reference compound Orlistat by using the porcine pancreatic lipase inhibitory test which was conducted by using a UV-visible spectrophotometer. Results: The aqueous extracts of Vitis vinifera and Rhus coriaria had the highest antilipase effects with IC50 values 14.13 and 19.95 mcg/mL, respectively. Meanwhile, the organic extract of Origanum dayi had an IC50 value 18.62 mcg/mL. V. vinifera showed the highest porcine pancreatic lipase inhibitory effects when compared with Orlistat, which has an IC50 value 12.38 mcg/mL. Conclusions: According to the obtained results, V. vinifera, R. coriaria, and O. dayi can be considered a natural inhibitors of the pancreatic lipase enzyme as well as new players in obesity treatment. In fact, these plants can be freely and safely consumed in a daily diet or can be prepared as nutraceutical formulations to treat or prevent of obesity. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
https://www.mdpi.com/2305-6320/4/4/89; https://doaj.org/toc/2305-6320; https://doaj.org/article/ab4b7f7ccaae41d59c619a0effdc2ca8 |
| DOI: |
10.3390/medicines4040089 |
| Availability: |
https://doi.org/10.3390/medicines4040089; https://doaj.org/article/ab4b7f7ccaae41d59c619a0effdc2ca8 |
| Accession Number: |
edsbas.CD15EF79 |
| Database: |
BASE |